DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Vfend (Voriconazole) - Hepatic Function Abnormal - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Hepatic Function Abnormal (15)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Vfend (Voriconazole) where reactions include hepatic function abnormal. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Vfend side effects in male

Reported by a pharmacist from United States on 2012-07-18

Patient: male, weighing 11.3 kg (24.9 pounds)

Reactions: Hepatic Function Abnormal, Rash, Skin Reaction

Drug(s) suspected as cause:
Vfend



Possible Vfend side effects in 50 year old female

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-05-24

Patient: 50 year old female, weighing 41.8 kg (92.0 pounds)

Reactions: Hepatic Function Abnormal, Abdominal Wall Haematoma, Renal Impairment, Diarrhoea, Constipation, Full Blood Count Decreased

Adverse event resulted in: death

Drug(s) suspected as cause:
Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2010-09-08
    End date: 2010-09-15

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Start date: 2010-09-16
    End date: 2010-09-25

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2010-10-12
    End date: 2010-10-14

Vfend
    Dosage: 400 milligram
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2010-09-01

Other drugs received by patient: Cotrim; Lansoprazole; Prednisolone; Morphine; Levothyroxine Sodium; Candesartan Cilexetil; Ozex; Urso 250; Polaramine; Fentanyl-100; Lendormin D; Gabapentin; Acetaminophen; Itraconazole; Restamin Cortisone; Prednisolone; Zometa; Fentanyl-100



Possible Vfend side effects in male

Reported by a physician from Japan on 2012-04-24

Patient: male

Reactions: Hepatic Function Abnormal, Cardiomyopathy

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Vfend



Possible Vfend side effects in male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-04-02

Patient: male, weighing 51.0 kg (112.2 pounds)

Reactions: Hepatic Function Abnormal, Renal Impairment, Pancytopenia

Adverse event resulted in: life threatening event, disablity

Drug(s) suspected as cause:
Ambisome
    Dosage: 120 mg, uid/qd
    Indication: Systemic Mycosis
    Start date: 2010-11-17
    End date: 2010-11-30

Ambisome
    Dosage: 165 mg, uid/qd
    Start date: 2010-12-01
    End date: 2010-12-10

Ambisome
    Dosage: 220 mg, uid/qd
    Indication: Cranial Nerve Disorder
    Start date: 2010-12-11
    End date: 2011-04-08

Fungizone
    Dosage: 50 mg, uid/qd
    Administration route: Topical
    Indication: Cranial Nerve Disorder
    Start date: 2011-01-13
    End date: 2011-01-13

Fungizone
    Dosage: 50 mg, uid/qd
    Administration route: Topical
    Start date: 2011-01-20
    End date: 2011-01-20

Fungizone
    Dosage: 50 mg, uid/qd
    Administration route: Topical
    Start date: 2011-02-17
    End date: 2011-02-17

Fungizone
    Dosage: 50 mg, uid/qd
    Administration route: Topical
    Start date: 2011-02-09
    End date: 2011-02-09

Fungizone
    Dosage: 50 mg, uid/qd
    Administration route: Topical
    Start date: 2011-02-03
    End date: 2011-02-03

Fungizone
    Dosage: 50 mg, uid/qd
    Administration route: Topical
    Indication: Fungal Infection
    Start date: 2011-01-06
    End date: 2011-01-06

Funguard
    Dosage: 150 mg, uid/qd
    Indication: Fungal Rhinitis
    Start date: 2010-12-18
    End date: 2011-04-12

Funguard
    Indication: Cranial Nerve Disorder

Funguard
    Indication: Systemic Mycosis

Vfend
    Dosage: 220 mg, bid
    Indication: Cranial Nerve Disorder
    Start date: 2011-01-11
    End date: 2011-04-09

Vfend
    Dosage: 200 mg, bid
    Administration route: Oral
    Start date: 2011-04-10
    End date: 2011-05-16

Vfend
    Dosage: 300 mg, bid
    Indication: Systemic Mycosis
    Start date: 2010-11-17
    End date: 2010-11-25

Vfend
    Dosage: 200 mg, bid
    Start date: 2010-12-02
    End date: 2011-01-10

Vfend
    Dosage: 300 mg, bid
    Administration route: Oral
    Start date: 2011-04-09
    End date: 2011-04-09

Other drugs received by patient: Epinastine Hydrochloride; Metformin HCL; Hydrocortisone Sodium Succinate; Humalog; Actos; Lantus; Meropenem; Kinedak



Possible Vfend side effects in male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-02-21

Patient: male, weighing 51.0 kg (112.2 pounds)

Reactions: Renal Impairment, Hepatic Function Abnormal, Pancytopenia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Ambisome
    Dosage: 120 mg, uid/qd
    Start date: 2010-11-17
    End date: 2010-11-30

Ambisome
    Dosage: 220 mg, uid/qd
    Indication: Systemic Mycosis
    Start date: 2010-12-11
    End date: 2011-04-08

Ambisome
    Dosage: 165 mg, uid/qd
    Start date: 2010-12-01
    End date: 2010-12-10

Fungizone
    Dosage: 50 mg, uid/qd
    Administration route: Topical
    Start date: 2011-01-20
    End date: 2011-01-20

Fungizone
    Dosage: 50 mg, uid/qd
    Administration route: Topical
    Start date: 2011-02-09
    End date: 2011-02-09

Fungizone
    Dosage: 50 mg, uid/qd
    Administration route: Topical
    Start date: 2011-01-06
    End date: 2011-01-06

Fungizone
    Dosage: 50 mg, uid/qd
    Administration route: Topical
    Start date: 2011-01-13
    End date: 2011-01-13

Fungizone
    Dosage: 50 mg, uid/qd
    Administration route: Topical
    Start date: 2011-02-03
    End date: 2011-02-03

Fungizone
    Dosage: 50 mg, uid/qd
    Indication: Fungal Infection
    Start date: 2011-02-17
    End date: 2011-02-17

Funguard
    Dosage: 150 mg, uid/qd
    Indication: Fungal Rhinitis
    Start date: 2010-12-18
    End date: 2011-04-12

Vfend
    Dosage: 300 mg, bid
    Indication: Cranial Nerve Disorder
    Start date: 2010-11-17
    End date: 2010-11-25

Vfend
    Dosage: 200 mg, bid
    Administration route: Oral
    Start date: 2011-04-10
    End date: 2011-05-16

Vfend
    Dosage: 220 mg, bid
    Indication: Systemic Mycosis
    Start date: 2011-01-11
    End date: 2011-04-09

Vfend
    Dosage: 300 mg, bid
    Administration route: Oral
    Start date: 2011-04-09
    End date: 2011-04-09

Vfend
    Dosage: 200 mg, bid
    Start date: 2010-12-02
    End date: 2011-01-10

Other drugs received by patient: Lantus; Humalog; Hydrocortisone Sodium Succinate; Metformin HCL; Actos; Epinastine Hydrochloride; Meropenem; Kinedak



Possible Vfend side effects in 98 year old female

Reported by a physician from Japan on 2012-02-15

Patient: 98 year old female

Reactions: Hepatic Function Abnormal, Hyperammonaemia, Pulmonary Mycosis

Adverse event resulted in: death

Drug(s) suspected as cause:
Ambisome
    Dosage: 100 mg, 1x/day
    Start date: 2011-09-03
    End date: 2011-09-09

Ambisome
    Dosage: 200 mg, 1x/day
    Indication: Pulmonary Mycosis
    Start date: 2011-09-02
    End date: 2011-09-02

Meropenem
    Dosage: 0.5 g, 2x/day
    Indication: Lobar Pneumonia
    Start date: 2011-08-26
    End date: 2011-08-30

Meropenem
    Dosage: 0.5 g, 2x/day
    Start date: 2011-09-04
    End date: 2011-09-08

Minocycline HCL
    Dosage: 100 mg, 2x/day
    Start date: 2011-09-05
    End date: 2011-09-06

Minocycline HCL
    Dosage: 200 mg, 1x/day
    Start date: 2011-09-04
    End date: 2011-09-04

Minocycline HCL
    Dosage: 100 mg, 1x/day
    Indication: Lobar Pneumonia
    Start date: 2011-08-26
    End date: 2011-08-30

Vfend
    Dosage: 200 mg, 2x/day
    Indication: Pulmonary Mycosis
    Start date: 2011-09-04
    End date: 2011-09-04

Vfend
    Dosage: 200 mg, 1x/day
    Start date: 2011-09-05
    End date: 2011-09-08

Other drugs received by patient: Teicoplanin; Teicoplanin; Hanp; Buprenorphine HCL; Micafungin Sodium; Miraclid; Haloperidol; Fragmin; Teicoplanin; Teicoplanin; Omeprazole; Ciprofloxacin; Prodif; Elaspol



Possible Vfend side effects in 74 year old female

Reported by a pharmacist from Japan on 2012-02-06

Patient: 74 year old female

Reactions: Hepatic Function Abnormal, Shock Haemorrhagic, Tremor, Decreased Appetite

Adverse event resulted in: death

Drug(s) suspected as cause:
Vfend
    Dosage: 400 mg/day
    Administration route: Oral
    Start date: 2011-11-16

Vfend
    Dosage: 400 mg/day
    Indication: Systemic Candida
    Start date: 2011-11-09
    End date: 2011-11-15

Other drugs received by patient: Paxil; Ketas; Depakene; Depas



Possible Vfend side effects in 74 year old female

Reported by a physician from Japan on 2012-01-31

Patient: 74 year old female

Reactions: Hepatic Function Abnormal, Shock Haemorrhagic, Decreased Appetite, Tremor

Adverse event resulted in: death

Drug(s) suspected as cause:
Vfend
    Dosage: 400 mg/day
    Administration route: Oral
    Start date: 2011-11-16

Vfend
    Dosage: 400 mg/day
    Indication: Systemic Candida
    Start date: 2011-11-09
    End date: 2011-11-15



Possible Vfend side effects in 98 year old female

Reported by a physician from Japan on 2012-01-23

Patient: 98 year old female

Reactions: Hepatic Function Abnormal, Hyperammonaemia, Pulmonary Mycosis

Adverse event resulted in: death

Drug(s) suspected as cause:
Ambisome
    Dosage: 200 mg, 1x/day
    Indication: Pulmonary Mycosis
    Start date: 2011-09-02
    End date: 2011-09-02

Ambisome
    Dosage: 100 mg, 1x/day
    Start date: 2011-09-03
    End date: 2011-09-09

Meropenem
    Dosage: 0.5 g, 2x/day
    Start date: 2011-09-04
    End date: 2011-09-08

Meropenem
    Dosage: 0.5 g, 2x/day
    Indication: Lobar Pneumonia
    Start date: 2011-08-26
    End date: 2011-08-30

Minocycline HCL
    Dosage: 100 mg, 2x/day
    Start date: 2011-09-05
    End date: 2011-09-06

Minocycline HCL
    Dosage: 100 mg, 1x/day
    Indication: Lobar Pneumonia
    Start date: 2011-08-26
    End date: 2011-08-30

Minocycline HCL
    Dosage: 200 mg, 1x/day
    Start date: 2011-09-04
    End date: 2011-09-04

Vfend
    Dosage: 200 mg, 2x/day
    Indication: Pulmonary Mycosis
    Start date: 2011-09-04
    End date: 2011-09-04

Vfend
    Dosage: 200 mg, 1x/day
    Start date: 2011-09-05
    End date: 2011-09-08

Other drugs received by patient: Prodif; Haloperidol; Buprenorphine HCL; Teicoplanin; Teicoplanin; Ciprofloxacin; Teicoplanin; Fragmin; Teicoplanin; Hanp; Micafungin Sodium; Omeprazole; Elaspol; Miraclid



Possible Vfend side effects in 98 year old female

Reported by a physician from Japan on 2012-01-17

Patient: 98 year old female

Reactions: Hepatic Function Abnormal, Hyperammonaemia, Pulmonary Mycosis

Adverse event resulted in: death

Drug(s) suspected as cause:
Ambisome
    Dosage: 200 mg, 1x/day
    Indication: Pulmonary Mycosis
    Start date: 2011-09-02
    End date: 2011-09-02

Ambisome
    Dosage: 100 mg, 1x/day
    Start date: 2011-09-03
    End date: 2011-09-09

Meropenem
    Dosage: 0.5 g, 2x/day
    Indication: Lobar Pneumonia
    Start date: 2011-08-26
    End date: 2011-08-30

Meropenem
    Dosage: 0.5 g, 2x/day
    Start date: 2011-09-04
    End date: 2011-09-08

Minocycline HCL
    Dosage: 100 mg, 1x/day
    Indication: Lobar Pneumonia
    Start date: 2011-08-26
    End date: 2011-08-30

Minocycline HCL
    Dosage: 200 mg, 1x/day
    Start date: 2011-09-04
    End date: 2011-09-04

Minocycline HCL
    Dosage: 100 mg, 2x/day
    Start date: 2011-09-05
    End date: 2011-09-06

Vfend
    Dosage: 200 mg, 1x/day
    Start date: 2011-09-05
    End date: 2011-09-08

Vfend
    Dosage: 200 mg, 2x/day
    Indication: Pulmonary Mycosis
    Start date: 2011-09-04
    End date: 2011-09-04

Other drugs received by patient: Miraclid; Teicoplanin; Teicoplanin; Teicoplanin; Haloperidol; Fragmin; Micafungin Sodium; Hanp; Teicoplanin; Omeprazole; Prodif; Elaspol; Ciprofloxacin; Buprenorphine HCL



Possible Vfend side effects in 61 year old male

Reported by a physician from Japan on 2012-01-17

Patient: 61 year old male

Reactions: Hepatic Function Abnormal, Renal Impairment, Visual Impairment, Paralysis, Pancytopenia

Drug(s) suspected as cause:
Amphotericin B
    Indication: Sinusitis Fungal

Micafungin
    Indication: Sinusitis Fungal

Vfend
    Indication: Sinusitis Fungal



Possible Vfend side effects in 74 year old female

Reported by a pharmacist from Japan on 2011-12-14

Patient: 74 year old female

Reactions: Aneurysm Ruptured, Hepatic Function Abnormal, Tremor, Decreased Appetite

Adverse event resulted in: death

Drug(s) suspected as cause:
Vfend
    Dosage: 400 mg/day
    Administration route: Oral
    Start date: 2011-11-16

Vfend
    Dosage: 400 mg/day
    Indication: Systemic Candida
    Start date: 2011-11-09
    End date: 2011-11-15



Possible Vfend side effects in 89 year old male

Reported by a physician from Japan on 2011-11-04

Patient: 89 year old male, weighing 48.0 kg (105.6 pounds)

Reactions: Hepatic Function Abnormal, Pleural Effusion, Generalised Oedema

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Vfend
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    Start date: 2010-11-24
    End date: 2010-12-13

Vfend
    Dosage: 400 mg, 2x/day
    Administration route: Oral
    Indication: Sinusitis Fungal
    Start date: 2010-11-23
    End date: 2010-11-23

Other drugs received by patient: Adalat; Aldactone; Magnesium Oxide; Ambisome; Amlodipine; Amaryl; Pursennid; Lasix; Carvedilol; Sigmart; Primperan TAB; Olmesartan Medoxomil; Lipitor; Actos; Lendormin



Possible Vfend side effects in 98 year old female

Reported by a physician from Japan on 2011-10-24

Patient: 98 year old female

Reactions: Death, Hepatic Function Abnormal, Ammonia Increased

Adverse event resulted in: death

Drug(s) suspected as cause:
Vfend
    Dosage: 800 mg/day
    Indication: Pulmonary Mycosis
    Start date: 2011-09-04
    End date: 2011-09-04

Vfend
    Dosage: 400 mg/day
    Start date: 2011-09-05
    End date: 2011-09-08



Possible Vfend side effects in female

Reported by a pharmacist from Japan on 2011-10-04

Patient: female, weighing 56.4 kg (124.1 pounds)

Reactions: Renal Impairment, Hepatic Function Abnormal, Hepatic Neoplasm Malignant

Adverse event resulted in: death

Drug(s) suspected as cause:
Levofloxacin
    Dosage: 500 mg, 1x/day
    Start date: 2011-08-28
    End date: 2011-09-05

Vancomycin
    Dosage: 750 mg, 2x/day
    Start date: 2011-08-30
    End date: 2011-09-02

Vancomycin
    Dosage: 1000 mg, 2x/day
    Start date: 2011-08-24
    End date: 2011-08-29

Vfend
    Dosage: 100 mg, 2x/day
    Start date: 2011-08-29
    End date: 2011-09-01

Vfend
    Dosage: 300 mg, 2x/day
    Start date: 2011-08-28
    End date: 2011-08-28

Vfend
    Dosage: 100 mg, 2x/day
    Administration route: Oral
    Start date: 2011-09-02
    End date: 2011-09-07

Other drugs received by patient: Alprostadil; Omeprazole; Antithrombin III Human; Propofol; Immunoglobulin Human Normal; FOY; Heparin Sodium; Meropenem; Sandostatin; Antithrombin III Human; Heparin Sodium; Fentanyl

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014